Table 4.

Recording and control of lipids, blood pressure, glucose and HbA1c, and Cardiovascular Health Index Score, SUrvey of Risk Factors I, by region.

OverallEuropeAsiaMiddle Eastp valuea
Lipid
 Known history of dyslipidaemia, %67.668.747.288.9<0.001
 Total cholesterol, mmol/l4.1 (8320)4.1 (5506)4.2 (1598)3.7 (1216)0.001
 LDL cholesterol, mmol/l2.3 (7672)2.2 (4872)2.6 (1532)2.0 (1268)0.001
 HDL cholesterol, mmol/l1.1 (7780)1.1 (5036)1.1 (1533)0.9 (1211)0.001
 Triglycerides, mmol/l1.4 (8130)1.4 (5291)1.4 (1610)1.4 (1229)0.083
At targets, %b
 Total cholesterol, mmol/l62.359.260.379.4<0.001
 LDL cholesterol, mmol/l59.460.245.273.4<0.001
 Stricter LDL cholesterol, mmol/l29.732.914.635.6<0.001
Blood pressure
 Known history of hypertension74.571.777.283.9<0.001
Physical measurements
 Systolic blood pressure, mmHg131.5 ± 18.6132.4 ± 19.5130.7 ± 16.4128.4 ± 17.2<0.001
 Diastolic blood pressure, mmHg76.1 ± 11.077.0 ± 10.877.0 ± 10.971.5 ± 10.40.111
 Heart rate, beats/min70.9 ± 12.770.2 ± 13.073.6 ± 12.470.8 ± 11.4<0.001
At target, %b
 Blood pressure6057.659.470.6<0.001
 Known history of diabetes, %34.525.24076.1<0.001
 Type I diabetes2.11.60.115.3<0.001
 Type II diabetes32.923.839.873.7<0.001
 Glucose, mmol/l5.7 (7891)5.6 (5167)5.8 (1524)6.6 (1200)0.001
 Non-diabetics5.5 (5688)5.5 (4082)5.3 (899)6.0 (707)0.001
 Diabetics7.4 (2203)7.4 (1085)6.9 (625)8.3 (493)0.001
 HbA1c, %7.4 ± 1.67.3 ± 1.57.3 ± 1.57.9 ± 1.80.001
 Non-diabetics7.1 ± 1.76.8 ± 1.46.0 ± 0.97.7 ± 1.80.001
 Diabetics7.5 ± 1.67.6 ± 1.57.0 ± 1.48.3 ± 1.80.001
HbA1c at target, %b
 Overall48.247.664.535.2<0.001
 Non-diabetics57.863.790.642<0.001
 Diabetics42.138.656.626.2<0.001
CHIS, %c
 Poor21.419.919.131.2 <0.001
 Intermediate61.963.062.057.3
 Good16.717.118.911.6
OverallEuropeAsiaMiddle Eastp valuea
Lipid
 Known history of dyslipidaemia, %67.668.747.288.9<0.001
 Total cholesterol, mmol/l4.1 (8320)4.1 (5506)4.2 (1598)3.7 (1216)0.001
 LDL cholesterol, mmol/l2.3 (7672)2.2 (4872)2.6 (1532)2.0 (1268)0.001
 HDL cholesterol, mmol/l1.1 (7780)1.1 (5036)1.1 (1533)0.9 (1211)0.001
 Triglycerides, mmol/l1.4 (8130)1.4 (5291)1.4 (1610)1.4 (1229)0.083
At targets, %b
 Total cholesterol, mmol/l62.359.260.379.4<0.001
 LDL cholesterol, mmol/l59.460.245.273.4<0.001
 Stricter LDL cholesterol, mmol/l29.732.914.635.6<0.001
Blood pressure
 Known history of hypertension74.571.777.283.9<0.001
Physical measurements
 Systolic blood pressure, mmHg131.5 ± 18.6132.4 ± 19.5130.7 ± 16.4128.4 ± 17.2<0.001
 Diastolic blood pressure, mmHg76.1 ± 11.077.0 ± 10.877.0 ± 10.971.5 ± 10.40.111
 Heart rate, beats/min70.9 ± 12.770.2 ± 13.073.6 ± 12.470.8 ± 11.4<0.001
At target, %b
 Blood pressure6057.659.470.6<0.001
 Known history of diabetes, %34.525.24076.1<0.001
 Type I diabetes2.11.60.115.3<0.001
 Type II diabetes32.923.839.873.7<0.001
 Glucose, mmol/l5.7 (7891)5.6 (5167)5.8 (1524)6.6 (1200)0.001
 Non-diabetics5.5 (5688)5.5 (4082)5.3 (899)6.0 (707)0.001
 Diabetics7.4 (2203)7.4 (1085)6.9 (625)8.3 (493)0.001
 HbA1c, %7.4 ± 1.67.3 ± 1.57.3 ± 1.57.9 ± 1.80.001
 Non-diabetics7.1 ± 1.76.8 ± 1.46.0 ± 0.97.7 ± 1.80.001
 Diabetics7.5 ± 1.67.6 ± 1.57.0 ± 1.48.3 ± 1.80.001
HbA1c at target, %b
 Overall48.247.664.535.2<0.001
 Non-diabetics57.863.790.642<0.001
 Diabetics42.138.656.626.2<0.001
CHIS, %c
 Poor21.419.919.131.2 <0.001
 Intermediate61.963.062.057.3
 Good16.717.118.911.6

Numeric variables are mean ± standard deviation or median (number of measurements) and categorical variables are percentage. p values obtained from one-way analysis of variance test for numeric variables and Chi-square test for categorical variables.

a

Comparison between regions.

b

Total cholesterol target is <4.5 mmol/l; LDL cholesterol target is <2.5 mmol/l and stricter LDL cholesterol target is 1.8 mmol/l; blood pressure target is defined as: <140/90 mmHg, and <140/80 mmHg for diabetics.

c

CHIS categories were defined by the summed number of controlled risk factors: poor ≤2, intermediate =3 or 4, good =5 or 6.

LDL: low-density lipoprotein; HDL: high-density lipoprotein; CHIS: Cardiovascular Health Index Score

Table 4.

Recording and control of lipids, blood pressure, glucose and HbA1c, and Cardiovascular Health Index Score, SUrvey of Risk Factors I, by region.

OverallEuropeAsiaMiddle Eastp valuea
Lipid
 Known history of dyslipidaemia, %67.668.747.288.9<0.001
 Total cholesterol, mmol/l4.1 (8320)4.1 (5506)4.2 (1598)3.7 (1216)0.001
 LDL cholesterol, mmol/l2.3 (7672)2.2 (4872)2.6 (1532)2.0 (1268)0.001
 HDL cholesterol, mmol/l1.1 (7780)1.1 (5036)1.1 (1533)0.9 (1211)0.001
 Triglycerides, mmol/l1.4 (8130)1.4 (5291)1.4 (1610)1.4 (1229)0.083
At targets, %b
 Total cholesterol, mmol/l62.359.260.379.4<0.001
 LDL cholesterol, mmol/l59.460.245.273.4<0.001
 Stricter LDL cholesterol, mmol/l29.732.914.635.6<0.001
Blood pressure
 Known history of hypertension74.571.777.283.9<0.001
Physical measurements
 Systolic blood pressure, mmHg131.5 ± 18.6132.4 ± 19.5130.7 ± 16.4128.4 ± 17.2<0.001
 Diastolic blood pressure, mmHg76.1 ± 11.077.0 ± 10.877.0 ± 10.971.5 ± 10.40.111
 Heart rate, beats/min70.9 ± 12.770.2 ± 13.073.6 ± 12.470.8 ± 11.4<0.001
At target, %b
 Blood pressure6057.659.470.6<0.001
 Known history of diabetes, %34.525.24076.1<0.001
 Type I diabetes2.11.60.115.3<0.001
 Type II diabetes32.923.839.873.7<0.001
 Glucose, mmol/l5.7 (7891)5.6 (5167)5.8 (1524)6.6 (1200)0.001
 Non-diabetics5.5 (5688)5.5 (4082)5.3 (899)6.0 (707)0.001
 Diabetics7.4 (2203)7.4 (1085)6.9 (625)8.3 (493)0.001
 HbA1c, %7.4 ± 1.67.3 ± 1.57.3 ± 1.57.9 ± 1.80.001
 Non-diabetics7.1 ± 1.76.8 ± 1.46.0 ± 0.97.7 ± 1.80.001
 Diabetics7.5 ± 1.67.6 ± 1.57.0 ± 1.48.3 ± 1.80.001
HbA1c at target, %b
 Overall48.247.664.535.2<0.001
 Non-diabetics57.863.790.642<0.001
 Diabetics42.138.656.626.2<0.001
CHIS, %c
 Poor21.419.919.131.2 <0.001
 Intermediate61.963.062.057.3
 Good16.717.118.911.6
OverallEuropeAsiaMiddle Eastp valuea
Lipid
 Known history of dyslipidaemia, %67.668.747.288.9<0.001
 Total cholesterol, mmol/l4.1 (8320)4.1 (5506)4.2 (1598)3.7 (1216)0.001
 LDL cholesterol, mmol/l2.3 (7672)2.2 (4872)2.6 (1532)2.0 (1268)0.001
 HDL cholesterol, mmol/l1.1 (7780)1.1 (5036)1.1 (1533)0.9 (1211)0.001
 Triglycerides, mmol/l1.4 (8130)1.4 (5291)1.4 (1610)1.4 (1229)0.083
At targets, %b
 Total cholesterol, mmol/l62.359.260.379.4<0.001
 LDL cholesterol, mmol/l59.460.245.273.4<0.001
 Stricter LDL cholesterol, mmol/l29.732.914.635.6<0.001
Blood pressure
 Known history of hypertension74.571.777.283.9<0.001
Physical measurements
 Systolic blood pressure, mmHg131.5 ± 18.6132.4 ± 19.5130.7 ± 16.4128.4 ± 17.2<0.001
 Diastolic blood pressure, mmHg76.1 ± 11.077.0 ± 10.877.0 ± 10.971.5 ± 10.40.111
 Heart rate, beats/min70.9 ± 12.770.2 ± 13.073.6 ± 12.470.8 ± 11.4<0.001
At target, %b
 Blood pressure6057.659.470.6<0.001
 Known history of diabetes, %34.525.24076.1<0.001
 Type I diabetes2.11.60.115.3<0.001
 Type II diabetes32.923.839.873.7<0.001
 Glucose, mmol/l5.7 (7891)5.6 (5167)5.8 (1524)6.6 (1200)0.001
 Non-diabetics5.5 (5688)5.5 (4082)5.3 (899)6.0 (707)0.001
 Diabetics7.4 (2203)7.4 (1085)6.9 (625)8.3 (493)0.001
 HbA1c, %7.4 ± 1.67.3 ± 1.57.3 ± 1.57.9 ± 1.80.001
 Non-diabetics7.1 ± 1.76.8 ± 1.46.0 ± 0.97.7 ± 1.80.001
 Diabetics7.5 ± 1.67.6 ± 1.57.0 ± 1.48.3 ± 1.80.001
HbA1c at target, %b
 Overall48.247.664.535.2<0.001
 Non-diabetics57.863.790.642<0.001
 Diabetics42.138.656.626.2<0.001
CHIS, %c
 Poor21.419.919.131.2 <0.001
 Intermediate61.963.062.057.3
 Good16.717.118.911.6

Numeric variables are mean ± standard deviation or median (number of measurements) and categorical variables are percentage. p values obtained from one-way analysis of variance test for numeric variables and Chi-square test for categorical variables.

a

Comparison between regions.

b

Total cholesterol target is <4.5 mmol/l; LDL cholesterol target is <2.5 mmol/l and stricter LDL cholesterol target is 1.8 mmol/l; blood pressure target is defined as: <140/90 mmHg, and <140/80 mmHg for diabetics.

c

CHIS categories were defined by the summed number of controlled risk factors: poor ≤2, intermediate =3 or 4, good =5 or 6.

LDL: low-density lipoprotein; HDL: high-density lipoprotein; CHIS: Cardiovascular Health Index Score

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close